Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Red White & Bloom BrandsXCNQ:RWB EV-to-FCF is -63.12 as of Aug. 29, 2026. The stock has 7 warning signs investors should review. Among 559 Drug Manufacturers companies, Red White & Bloom Brands ranks worse than 178890.7% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Red White & Bloom Brands's Enterprise Value is C$432.14 Mil.
Red White & Bloom Brands's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was C$-6.85 Mil. Therefore, Red White & Bloom Brands's EV-to-FCF for today is -63.12.
The historical rank and industry rank for Red White & Bloom Brands's EV-to-FCF or its related term are showing as below:
XCNQ:RWB'
s EV-to-FCF Range Over the Past 10 Years
Min: -63.91 Med: -9.3 Max: -0.68
Current: -63.12
During the past 7 years, the highest EV-to-FCF of Red White & Bloom Brands was -0.68. The lowest was -63.91. And the median was -9.30.
XCNQ:RWB's EV-to-FCF is ranked worse than 100% of 559
companies
in the Drug Manufacturers industry
Industry Median: 20.58
vs XCNQ:RWB: -63.12
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Red White & Bloom Brands (XCNQ:RWB) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Red White & Bloom Brands's PE Ratio (TTM) for today is calculated as:
Red White & Bloom Brands's share price for today is C$0.03.
Red White & Bloom Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.204.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Red White & Bloom Brands EV-to-FCF Related Terms
Red White & Bloom Brands EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Red White & Bloom Brands's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Red White & Bloom Brands EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Red White & Bloom Brands's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Red White & Bloom Brands's EV-to-FCF falls into.
Red White & Bloom Brands's current Enterprise Value is C$432.14 Mil.
Red White & Bloom Brands's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-6.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Red White & Bloom Brands (XCNQ:RWB) has a EV-to-FCF of -63.12 as of Aug. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Red White & Bloom Brands and its competitors. According to the industry distribution chart, Red White & Bloom Brands ranks #999999 out of 559 companies in the Drug Manufacturers industry.
Is Red White & Bloom Brands' EV-to-FCF too high?
Red White & Bloom Brands' current EV-to-FCF is -63.12. Based on the distribution chart, Red White & Bloom Brands ranks #999999 out of 559 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Red White & Bloom Brands' EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Red White & Bloom Brands ranks #999999 out of 559 companies for EV-to-FCF. This places Red White & Bloom Brands in the lower half of its industry. The industry median EV-to-FCF is 20.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.58, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Red White & Bloom Brands and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Red White & Bloom Brands's current EV-to-FCF is -63.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Red White & Bloom Brands stock overvalued right now?
Based on GuruFocus' analysis, Red White & Bloom Brands (XCNQ:RWB) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.04, compared to a current price of C$0.03 — trading 25% below its estimated fair value. The current EV-to-FCF is -63.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Red White & Bloom Brands (XCNQ:RWB), the current EV-to-FCF is -63.12 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Red White & Bloom Brands Inc is a multi-state operator in the United States conducting operations in the legal cannabis industry. The principal activity of the company is the sale of a diverse range of high-quality cannabis-based products delivered through its distribution and retail channels. The company operates twelve licensed adult-use and medical retail dispensaries located in the legal states of Michigan and Florida. The company operates in reportable segments: Corporate segment, Distribution segment, Licensing segment, Retail segment and Other. The key revenue is generated from Distribution segment. Geographically, the company operates in USA and Canada, where majority revenue is generated from USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:RWB has been successfully added to your 
